US Drug Recall Register
Class III · Low risk Terminated Initiated Nov 27, 2018 (8 years ago)

Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.

What was recalled

Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430. UPC 368462583401. NDC 68462-583-40

Recalling firm
Glenmark Pharmaceuticals Inc., USA
NDC code
68462-583-40
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0349-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Aprepitant recalls

See all